Opioid

Is J&J nearing the end of its opioid liability hangover?

Johnson & Johnson and the ‘big three’ US pharma wholesalers are on the brink of a $26 billion settlement deal covering thousands of lawsuits alleging their involvement in contributing to the US opioid crisis, according to press reports. Under the deal, J&J would be in line for a $5 billion payment over nine years, while …

Is J&J nearing the end of its opioid liability hangover? Read More »

Purdue to pay $8.3bn after admitting criminal charges in opioid case

After years of legal wrangling, Purdue Pharma has agreed a deal to resolve litigation about its role in the US opioid epidemic that will cost it up to $8.3 billion. As part of the criminal and civil settlement, the manufacturer of opioid painkiller OxyContin (oxycodone) pleaded guilty to a three-count felony, including two counts of …

Purdue to pay $8.3bn after admitting criminal charges in opioid case Read More »

After final $600M opioid settlement, Indivior looks to the future

UK drugmaker Indivior looks finally to have put years of uncertainty over its exposure to opioid litigation in the US behind it, after agreeing a $600 million settlement. The deal resolves criminal and civil liabilities faced by the company related to charges it engaged in an illicit nationwide scheme to increase prescriptions of opioid addiction …

After final $600M opioid settlement, Indivior looks to the future Read More »

More opioid negative externalities: Pediatric opioid poisoning

Some people use opioids as a recreational drug. If people choose to ruin their own life, that is their problem. Others take opioids when prescribed from physicians and unwittingly become addicted. In either case, there is one scourge that may not fully be appreciated: parents who take opioids risk having their kids go into their …

More opioid negative externalities: Pediatric opioid poisoning Read More »